TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BO-112

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

BO-112

ST13

US500000088240297

Class

5

Filing

88240297

Registration

6172311

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

10/14/2025

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

12/23/2018

Registration date

10/13/2020

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/13/2020

Last transaction

10/14/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

PATERNA, VALENCIA, ES

Examiner

PASSMAN,NICOLE A

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

HIGHLIGHT THERAPEUTICS, S.L.
B. S. (pessoa física)

Representatives

STACEY J. FARMER GRUND INTELLECTUAL PROPERTY GROUP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for cancer; Anti-cancer preparations; Biological preparations for the treatment of cancer; Medical preparations for the treatment of cancer; Medicinal preparations for cancer; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer; Veterinary pharmaceutical preparations for the prevention of cancer; Veterinary pharmaceutical preparations for the treatment of cancer

Publications

History of USPTO decisions and trademark events.

26 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/13/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/13/2020

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/26/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/28/2020

PUBO

PUBLISHED FOR OPPOSITION

07/28/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/08/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/22/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

05/22/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/22/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

05/22/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/22/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/21/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/21/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/21/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/21/2019

GNRT

NON-FINAL ACTION E-MAILED

11/21/2019

CNRT

NON-FINAL ACTION WRITTEN

11/21/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/11/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/11/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/11/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/18/2019

GNRT

NON-FINAL ACTION E-MAILED

03/18/2019

CNRT

NON-FINAL ACTION WRITTEN

03/18/2019

DOCK

ASSIGNED TO EXAMINER

03/18/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/16/2019

NWAP

NEW APPLICATION ENTERED

12/26/2018

Continuous trademark protection

Get notified about every new filing that threatens BO-112 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.